| abstract |
This invention relates to the use of (S) -3-oxo-8- [3- (pyridin-2-ylamino) -1-propyloxy] -2- (2,2,2-trifluoroethyl) -2,3,4,5 -tetrahydro-1H-2-benzazepine-4-acetic acid and (S) -8- [2- [6- (methylamino) pyridin-2-yl] -1-ethoxy] -3-oxo-2- (2, 2,2-trifluoroethyl) -2,3,4,5-tetrahydro-1H-2-benzazepine-4-acetic acid or their pharmaceutically acceptable salts to inhibit the formation of adhesions in a mammal. |